Annual report pursuant to Section 13 and 15(d)

Note 8 - Stockholders' Deficit - Stock Options (Details)

v3.19.1
Note 8 - Stockholders' Deficit - Stock Options (Details) - USD ($)
12 Months Ended
Oct. 01, 2017
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Outstanding, Number of Shares (in shares)   15,000  
Outstanding, Weighted Average Exercise Price (in dollars per share)   $ 0.13  
Outstanding, Weighted Average Remaining Life (Year)   9 years 160 days 9 years 273 days
Granted, Number of Shares (in shares) 15,000 2,220,000 15,000  
Granted, Weighted Average Exercise Price (in dollars per share) $ 0.13 $ 1.75 $ 0.13  
Outstanding, Number of Shares (in shares)   2,235,000 15,000
Outstanding, Weighted Average Exercise Price (in dollars per share)   $ 1.74 $ 0.13
Outstanding, Aggregate Intrinsic Value   $ 23,100    
Exercisable, Number of Shares (in shares)   7,500    
Exercisable, Weighted Average Exercise Price (in dollars per share)   $ 0.13    
Exercisable, Weighted Average Remaining Life (Year)   8 years 277 days    
Exercisable, Aggregate Intrinsic Value   $ 11,550